派博傳思國(guó)際中心

標(biāo)題: Titlebook: Nano-Oncologicals; New Targeting and De Maria José Alonso,Marcos Garcia-Fuentes Book 2014 Controlled Release Society 2014 EPR.RNA delivery. [打印本頁]

作者: 出租車    時(shí)間: 2025-3-21 19:30
書目名稱Nano-Oncologicals影響因子(影響力)




書目名稱Nano-Oncologicals影響因子(影響力)學(xué)科排名




書目名稱Nano-Oncologicals網(wǎng)絡(luò)公開度




書目名稱Nano-Oncologicals網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nano-Oncologicals被引頻次




書目名稱Nano-Oncologicals被引頻次學(xué)科排名




書目名稱Nano-Oncologicals年度引用




書目名稱Nano-Oncologicals年度引用學(xué)科排名




書目名稱Nano-Oncologicals讀者反饋




書目名稱Nano-Oncologicals讀者反饋學(xué)科排名





作者: 吹牛需要藝術(shù)    時(shí)間: 2025-3-21 21:58
Nano-Oncologicals978-3-319-08084-0Series ISSN 2192-6204 Series E-ISSN 2192-6212
作者: 事物的方面    時(shí)間: 2025-3-22 04:12
Advances in Delivery Science and Technologyhttp://image.papertrans.cn/n/image/660633.jpg
作者: Expurgate    時(shí)間: 2025-3-22 08:20
https://doi.org/10.1007/978-3-319-08084-0EPR; RNA delivery; biomarkers; liposomes; nanoparticles
作者: Mumble    時(shí)間: 2025-3-22 10:06
Targeted Liposomes and Micelles as Carriers for Cancer Therapyand to minimize potential drug toxicity. A variety of targeting strategies, such as active targeting, tumor microenvironment responsive targeting and triggered targeting, have given crucial pulses to the design and development of novel drug delivery systems for cancer therapy.
作者: 打擊    時(shí)間: 2025-3-22 15:57

作者: nonchalance    時(shí)間: 2025-3-22 18:37
Book 2014ss simultaneously diverse issues of clinical relevance in the treatment of cancer. The book consists of sixteen chapters divided into six sections: 1) Biological Barriers in Cancer; 2) Tumor Targeting; 3) Targeting the Immune System; 4) Gene Therapy; 5) Nano theranostics and 6) Translational Aspects
作者: prosperity    時(shí)間: 2025-3-22 22:18
2192-6204 ding targeted therapies, immunomodulation and emerging thera.This authoritative volume focuses on emerging technologies in cancer nano medicine, characterized by their multi-functionality and potential to address simultaneously diverse issues of clinical relevance in the treatment of cancer. The boo
作者: Atrium    時(shí)間: 2025-3-23 01:26
Microbubbles as Theranostics Agentstreatment and protein/gene therapies. The work reviewed here is only a small fraction of the literature available on the subject matter and serves as an introduction to microbubbles as contrast agents, drug delivery vehicles, and theranostic particles.
作者: Influx    時(shí)間: 2025-3-23 08:31

作者: 夾死提手勢(shì)    時(shí)間: 2025-3-23 12:00

作者: 食草    時(shí)間: 2025-3-23 17:36
The “EX” and the “SOMA”: How They Communicate close or far away target cells is mostly unknown. As we improve our understanding of the biological fate of exosomal-miRNA, we will most likely obtain insights into the mechanisms involved in these events. Exosome mediated drug delivery is a promising strategy to efficiently deliver antitumor miRNA
作者: 看法等    時(shí)間: 2025-3-23 21:28
Polymeric Nanocarriers for Cancer Therapyseveral types of targeting ligands could be used for active targeting. Furthermore, polymeric nanocarriers have been functionalized to release encapsulated drugs at specific sites or time intervals controlled by environmental triggers, such as pH, temperature, and enzyme. Finally, the application of
作者: 領(lǐng)導(dǎo)權(quán)    時(shí)間: 2025-3-23 22:38

作者: 裂口    時(shí)間: 2025-3-24 02:24
Cancer Immune Modulation and Immunosuppressive Cells: Current and Future Therapeutic Approachescribed, together with other pharmacological and nucleic acid-based strategies, which may take advantage of nanosystems to increase their effectiveness and selectivity. The application of nanotechnology to immunosuppressive and tumor-promoting cell targeting may provide a powerful tool to improve can
作者: indoctrinate    時(shí)間: 2025-3-24 08:49

作者: Instinctive    時(shí)間: 2025-3-24 13:02
RNAi-Based Nano-Oncologicals: Delivery and Clinical Applicationsuence-defined oligomers can be designed which combine multifunctionality with precision. Functional domains for increased binding of the nucleic acid, receptor targeting and protection of polyplexes against undesired interactions, or enhancing the endosomal escape into the cytosol can be assembled i
作者: 大雨    時(shí)間: 2025-3-24 16:57

作者: 合群    時(shí)間: 2025-3-24 20:28
Multifunctional Gold Nanocarriers for Cancer Theranostics: From Bench to Bedside and Back Again?most likely revolutionize our understanding of biological mechanisms and push forward the clinical practice through their integration in future diagnostics platforms. Nevertheless, very little gave fruitful results in order to improve a bench-to-bedside approach to translational research. On the bas
作者: 后退    時(shí)間: 2025-3-24 23:41
Multimodal Nano-Systems for Cancer Diagnosis, Imaging, and Therapyok chapter focuses on progresses in the nanotechnology-based strategies for diagnosis, imaging, and therapy of cancer with illustrative examples from the recent literature. Such . are designed to evade recognition from host’s immune system, exploit the tumor microenvironment to accumulate at the des
作者: anticipate    時(shí)間: 2025-3-25 06:11

作者: Cholagogue    時(shí)間: 2025-3-25 08:46

作者: Inscrutable    時(shí)間: 2025-3-25 14:32
Jaydev R. Upponi,Vladimir P. Torchilinperiod has tended to disappear from view lies in the sense of historical and aesthetic difference, and productive failure, which this study uncovers...?.978-3-319-87914-7978-3-319-64970-2Series ISSN 2634-6516 Series E-ISSN 2634-6524
作者: sinoatrial-node    時(shí)間: 2025-3-25 19:20

作者: 先行    時(shí)間: 2025-3-25 23:38
2192-6204 t analyzes in detail the possibility of either improving the efficiency of the immune system toward preventing cancer progression (cancer immunomodulation) or generating responses against specific cancer antige978-3-319-34485-0978-3-319-08084-0Series ISSN 2192-6204 Series E-ISSN 2192-6212
作者: 哀求    時(shí)間: 2025-3-26 01:41

作者: 補(bǔ)角    時(shí)間: 2025-3-26 07:46
t of appearance and severity. This chapter, then, offers a new reading of ., connecting the novel’s concern with the rhythm of the seasons with its fractal narrative poetics. . engagement with climate irregularities on the level of narrative design suggests how Austen responded to the ‘Year Without
作者: 土產(chǎn)    時(shí)間: 2025-3-26 09:00
Peng Mi,Nobuhiro Nishiyamathis volume and considers the way in which the mature odes of 1819 might be re-read within a wider consideration of Regency climate change. Finally, it turns to twenty-first-century poetry on climate change to argue for the legacy of Keats’s vision in our historical and climatic moment.
作者: sclera    時(shí)間: 2025-3-26 16:38

作者: 圓木可阻礙    時(shí)間: 2025-3-26 20:17

作者: JECT    時(shí)間: 2025-3-26 21:55

作者: expdient    時(shí)間: 2025-3-27 02:12

作者: URN    時(shí)間: 2025-3-27 09:04
Maria Stella Sasso,Vincenzo Bronte,Ilaria Marigoiginally] reside in the human breast” (E 38). In Blake’s later account of the operation of “Science [as] the Tree of Death” (E 274) in ., Western enlightenment forms of knowledge follow this same movement from interiority to exteriority, where the “Newtonian phantasm” (E 141) establishes a mechanica
作者: JEER    時(shí)間: 2025-3-27 09:57

作者: fabricate    時(shí)間: 2025-3-27 14:07
h it the prisoners who had been in limbo since 1784, men not dangerous enough to hang but too much of a social menace to pardon. Some were veterans of the Woolwich hulks like George Barrington, who had fulfilled the direst prophecies about future recidivism by graduating from petty pickpocketing to
作者: 夾克怕包裹    時(shí)間: 2025-3-27 21:19
Katharina Müller,Ernst Wagnerera, poets such as Samuel Taylor Coleridge and William Wordsworth were drawn to the figure of the iconoclast or the outsider. Lord Byron and Percy Bysshe Shelley chose to live out what proved to be the last years of their lives on the continent, embracing the idea of self-exile dramatized by Byron’s
作者: 能夠支付    時(shí)間: 2025-3-27 21:59

作者: Interstellar    時(shí)間: 2025-3-28 02:06
, the spatial dimension of Romantic poetics underwent a period of inflation that matched the extension of space offered in Kant’s postulation of a universe of galaxies and the more limited expansion of the solar system by Herschel’s discovery of a new planet, Uranus. As Ivors Leclerc notes, ‘By the
作者: 殘廢的火焰    時(shí)間: 2025-3-28 09:32
Jo?o Conde,Furong Tian,Pedro V. Baptista,Jesús M. de la Fuenteggest, however, that he was a straightforward Tory imperialist; recent criticism has uncovered a complex and ambivalent writer whose sympathies could be liberal as well as conservative.. . itself is hardly straightforward, but nonetheless it typifies a mid-century cultural shift towards a more aggre
作者: Custodian    時(shí)間: 2025-3-28 10:40

作者: 廚房里面    時(shí)間: 2025-3-28 17:46
Amit Singh,Adwait J. Oka,Purva Pandya,Mansoor M. Amiji an attempt to explain the two initial responses here: the one that stresses continuities of creation (even as the latter word retains something of its strong sense); and the other point of emphasis moving against a consciously willed model of the enlightenment subject.
作者: Terminal    時(shí)間: 2025-3-28 19:33
an attempt to explain the two initial responses here: the one that stresses continuities of creation (even as the latter word retains something of its strong sense); and the other point of emphasis moving against a consciously willed model of the enlightenment subject.
作者: LINES    時(shí)間: 2025-3-29 00:34
Passive vs. Active Targeting: An Update of the EPR Role in Drug Delivery to Tumorsstered systemically resulting in toxicity to normal tissues, hence limiting their clinical application. To overcome these challenges, nanocarriers such as liposomes and micelles have been widely used to deliver APIs for cancer chemotherapy. Delivery of nanocarriers is achieved either via “passive ta
作者: 額外的事    時(shí)間: 2025-3-29 03:58
The “EX” and the “SOMA”: How They Communicateout the body. Our current knowledge about the communication mechanisms between exosomes and their target cells still remains limited. The interaction between exosomes and their target cells is likely to require exquisite specificity. The pairing between membrane fusion and trafficking proteins such
作者: animated    時(shí)間: 2025-3-29 08:22
Polymeric Nanocarriers for Cancer Therapyelective manner, and some polymeric nanocarriers have already been approved for clinical application while more are under clinical trial, demonstrating their promises for cancer therapy. In this chapter, the concept of polymeric nanocarriers, structure design, and preparation methods are introduced
作者: ELUDE    時(shí)間: 2025-3-29 13:11

作者: 漸強(qiáng)    時(shí)間: 2025-3-29 18:52

作者: 滔滔不絕地講    時(shí)間: 2025-3-29 22:15

作者: VEN    時(shí)間: 2025-3-30 01:42
Cancer Immune Modulation and Immunosuppressive Cells: Current and Future Therapeutic Approaches NK cells, and macrophages, are able to mount an anti-tumor immune response, which can impair tumor growth. Nonetheless, cancer progression is usually associated with the expansion of additional cell subsets that inhibit the natural immunity to tumors and actively support tumor growth, invasion, and
作者: 配置    時(shí)間: 2025-3-30 07:28

作者: myelography    時(shí)間: 2025-3-30 12:17

作者: APEX    時(shí)間: 2025-3-30 13:18

作者: Metamorphosis    時(shí)間: 2025-3-30 20:01
Multifunctional Gold Nanocarriers for Cancer Theranostics: From Bench to Bedside and Back Again?c transformation of the genome. However, the full understanding of the molecular onset of this disease is still far from achieved and the search for mechanisms of treatment will follow closely..It is here that nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. It
作者: gregarious    時(shí)間: 2025-3-30 20:57
Microbubbles as Theranostics Agentsith the advent of microbubbles as US contrast agents, this simple imaging technique has evolved into a tool capable of providing molecularly targeted visualization of disease and controlled delivery of therapeutics. The simple, yet robust, structure of the microbubble allows for both internal and ex




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
霍州市| 获嘉县| 青铜峡市| 左贡县| 望都县| 张家港市| 汕头市| 长沙县| 石棉县| 云浮市| 青冈县| 乌海市| 乌兰浩特市| 永顺县| 根河市| 三台县| 鄂州市| 永丰县| 宁蒗| 儋州市| 龙南县| 盐池县| 桂阳县| 梅河口市| 宾川县| 河曲县| 益阳市| 平顺县| 宝鸡市| 闸北区| 广州市| 新竹县| 乐陵市| 比如县| 大姚县| 永登县| 阿瓦提县| 吉隆县| 巴里| 平塘县| 武威市|